Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × dabrafenib × Endocrine × Clear all

Phase

Status

Active not recruiting 4 Recruiting 3 Completed 2 Withdrawn 1 Unknown 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 Endocrine 1 Dermatologic 1

Conditions

Thyroid Carcinoma, Anaplastic 1 Neoplasms 1 Melanoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

tivozanib 1 dabrafenib 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04418167 2025-09-03

JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

JS InnoPharm, LLC

Phase 1 Suspended

DermatologicEndocrineHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡